Hält derzeit Positionen bei Eyenovia Inc, Soleno Therapeutics Inc and Kindred Biosciences Inc
Position | Company | Period |
---|---|---|
Director | Eyenovia Inc | None - |
Independent Chairman of the Board | Soleno Therapeutics Inc | 1. Februar 2014 - |
Independent Director | Kindred Biosciences Inc | 2. April 2018 - |
Independent Director | Celgene Corp | 22. August 2007 - 20. November 2019 |
Independent Director | Tonix Pharmaceuticals Holding Corp | 14. Oktober 2011 - 5. September 2018 |
Independent Chairman of the Board | Chimerix Inc | 1. Februar 2013 - 1. Juni 2018 |
Independent Director | Kindred Biosciences Inc | 15. Februar 2013 - 23. Mai 2016 |
Independent Director | Boston Scientific Corp | 30. Oktober 2001 - 15. April 2016 |
Lead Independent Director | Pharmaceutical Product Development Inc | 1. Juli 2009 - 1. Januar 2016 |
Director | XenoPort Inc | 15. Juni 2012 - 19. Mai 2015 |
Chairman & CEO | Soleno Therapeutics Inc | 1. August 2007 - 1. Februar 2014 |
Independent Director | Maxygen Inc | 20. Juli 2001 - 29. August 2013 |
Independent Director | Vivus Inc | 18. April 2012 - 19. Juli 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2022-04-04 | 2022-03-31 |
Soleno Therapeutics Inc
(SLNO)
|
K Kauf |
930.000
0,000 USD |
930.000 | 0,00 | 0 USD | |
2022-04-04 | 2022-03-31 |
Soleno Therapeutics Inc
(SLNO)
|
K Kauf |
930.000
0,000 USD |
930.000 | 0,00 | 0 USD | |
2020-03-26 | 2020-03-24 |
Eyenovia Inc
(EYEN)
|
K Kauf |
82.431
+33.7%
2,27187.118 USD |
82.431 +33.7% | 2,27 | 187.118 USD | |
2019-07-15 | 2019-07-11 |
Eyenovia Inc
(EYEN)
|
K Kauf |
35.971
+15.2%
2,7899.999 USD |
35.971 +15.2% | 2,78 | 99.999 USD | |
2019-02-14 | 2019-02-12 |
Celgene Corp
(CELG)
|
K Kauf |
2.000
+inf%
89,99179.980 USD |
2.000 +inf% | 89,99 | 179.980 USD | |
2019-05-21 | 2018-01-29 |
Eyenovia Inc
(EYEN)
|
K Kauf |
90.000
+61.3%
10,00900.000 USD |
90.000 +61.3% | 10,00 | 900.000 USD | |
2016-12-29 | 2016-12-27 |
Chimerix Inc
(CMRX)
|
GV Geplanter Verkauf |
72.073
-19.6%
4,68337.143 USD |
72.073 -19.6% | 4,68 | 337.143 USD | |
2016-08-19 | 2016-08-18 |
Soleno Therapeutics Inc
(SLNO)
|
K Kauf |
25.000
+1.4%
0,9924.750 USD |
25.000 +1.4% | 0,99 | 24.750 USD | |
2016-05-23 | 2016-05-20 |
Soleno Therapeutics Inc
(SLNO)
|
K Kauf |
5.637
+0.3%
1,206.764 USD |
5.637 +0.3% | 1,20 | 6.764 USD | |
2015-08-25 | 2015-08-21 |
Soleno Therapeutics Inc
(SLNO)
|
K Kauf |
16.228
+1.1%
1,9130.995 USD |
16.228 +1.1% | 1,91 | 30.995 USD | |
2015-08-12 | 2015-08-11 |
Soleno Therapeutics Inc
(SLNO)
|
K Kauf |
50.000
+3.9%
1,7788.500 USD |
50.000 +3.9% | 1,77 | 88.500 USD | |
2004-05-05 | 2004-05-05 |
Ardea Biosciences Inc
(RDEA)
|
K Kauf |
20.000
+39.7%
13,00260.000 USD |
20.000 +39.7% | 13,00 | 260.000 USD | |
2004-05-06 | 2004-05-04 |
Boston Scientific Corp
(BSX)
|
K Kauf |
500
+0.5%
39,8619.930 USD |
500 +0.5% | 39,86 | 19.930 USD | |
2004-05-06 | 2004-05-04 |
Boston Scientific Corp
(BSX)
|
K Kauf |
2.200
+2.1%
39,8587.670 USD |
2.200 +2.1% | 39,85 | 87.670 USD |